Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study

Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study

Abstract Background Recipients of living donor renal transplantation are typically considered to have a relatively lower immunological risk. This retrospective study aimed to compare the therapeutic efficacy and safety between rabbit antithymocyte globulin (rATG) or interleukin-2 receptor antagonist...

Full description

Bibliographic Details
Main Authors: Jiang Qiu, Jun Li, Guodong Chen, Gang Huang, Qian Fu, Changxi Wang, Lizhong Chen
Format: Article
Language:English
Published: BMC 2019-03-01
Series:BMC Nephrology
Subjects:
Living donor renal transplantation
Induction therapy
Rabbit antithymocyte globulin (rATG)
Interleukin-2 receptor antagonist (IL2-RA)
Online Access:http://link.springer.com/article/10.1186/s12882-019-1293-2

Internet

http://link.springer.com/article/10.1186/s12882-019-1293-2

Similar Items